Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

Healthcare & Life Sciences Private Equity Deal Tracker: Carlyle Group Acquires J&J’s Ortho Clinical Diagnostics for $4.15 Billion

Posted in Healthcare Services Investing

PE firm Carlyle Group has announced it has agreed to acquire Johnson & Johnson’s Ortho Clinical Diagnostics business for $4.15 billion.

The transaction is expected to close in the middle of 2014.

Ortho Clinical Diagnostics, headquartered in Raritan, N.J., operates in 130 countries. It provides solutions for early screening, diagnosing, monitoring and confirming diseases, focused on supporting hospitals, laboratories and blood centers worldwide.

Carlyle Group, headquartered in Washington, D.C., is a global asset management firm specializing in PE. It has more than $185 billion in assets under management across 122 funds and 81 fund of funds vehicles. Since Carlyle’s inception, it has invested $6.3 billion of equity in healthcare transactions.

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.

Agree